Technology | Products | Clinical | Company | Contact




TransWorld Med Corporation was formed with the medical objective of dramatically improving the quality of life for cardiac transplant patients. Significant reduction in patient mortality will be achieved by the company's patented devices and algorithms. The noninvasive techniques and monitoring methodologies will be extremely useful in preventing hospitalizations and adverse outcomes associated with the painful biopsies currently utilized by the medical industry for these patients. TransWorld Med will facilitate the lowering of health costs for transplant recipients while appreciably improving their quality of life. This device and technology will therefore be easily embraced by physicians, insurance companies, and governmental third party payers. Extension of these medical technologies into other chronic disease processes will have a similar economic cost savings impact.

Copyright 2011 TransWorld Med Corporation. All rights reserved.
CRD(tm) is not available for sale in the US. CRD is an investigational device.